U.S. Basic Materials Stock News

Apple’s clash with the UK government over access to encrypted iCloud backups has pushed data privacy and cybersecurity back into the spotlight for investors. As regulators press harder on encryption and cross border data rules, some cybersecurity stocks exposed to this news look better placed than others. This article focuses on three stocks from a Cybersecurity Stocks screener that appear positively exposed to the current debate around privacy standards and regulatory scrutiny. You will see...

In late July 2026, Booz Allen Hamilton expanded its Vellox AI-powered cyber defense suite with Vellox Ranger, an agentic AI tool that automates environment-specific threat detection, while also reporting first-quarter fiscal 2027 results showing sales of US$2,800 million and net income of US$198 million, alongside continued dividends and share repurchases. Together with a new universal shelf registration and a broadened lineup of AI-driven cyber products, these developments highlight Booz...

SpaceX’s steep share price fall, heavy short selling and the pressure around its first earnings report have pushed downside protection and hedging tools into the spotlight. When a company with more than $500b in market cap wiped off experiences this kind of volatility, investors often look beyond the headline stock and toward products that can help manage risk or express a cautious view. This article walks through 3 stocks from a Short Sellers and Downside Protection Strategies screener that...

BankUnited, Inc. reported second-quarter 2026 results showing net interest income of US$255.33 million and net income of US$70.66 million, both modestly higher than a year earlier, with diluted EPS from continuing operations rising to US$0.97. Alongside this earnings improvement, the bank’s net charge-offs roughly halved to US$6.37 million and it completed a US$154.18 million buyback retiring 4.68% of its shares, underscoring management’s focus on credit quality and capital returns. We’ll...

Geopolitics, oil prices and interest rate expectations just collided in a way that puts US airlines and travel stocks back in focus. President Trump’s decision to cancel planned strikes on Iran eased conflict risks, helped pull oil sharply lower and coincided with a strong move in the Dow, S&P 500 and Nasdaq. That mix can quickly reshape expectations for fuel costs, demand and risk appetite. This article walks through 3 US airlines and travel stocks exposed to this news, explaining why some...

10x Genomics (TXG) stock is in focus after the company announced a multi year research collaboration with Lausanne University Hospital to study cancer diagnostics using its single cell and spatial platforms. See our latest analysis for 10x Genomics. The Lausanne collaboration lands at a moment when 10x Genomics has been in sharp focus, with the share price at US$47.27 and a 30 day share price return of 21.05% feeding into a 90 day share price return of 110.74% and a 1 year total shareholder...

In July 2026, First Merchants Corporation reported second-quarter and first-half results showing higher net interest income, with US$158.94 million for the quarter and US$310.24 million for the six months, compared with the prior year. Despite this revenue-related improvement, net income and earnings per share from continuing operations fell for both periods, highlighting pressure on overall profitability even as the bank’s core lending engine expanded. We’ll now examine how this mix of...

Over the last 7 days, the United States market has remained flat, yet it is up 18% over the past year with earnings projected to grow by 16% annually in the coming years. In this environment, identifying stocks that are trading below their fair value can present opportunities for investors looking to capitalize on potential growth while minimizing risk.

Over the last 7 days, the United States market has remained flat, yet it has experienced an impressive 18% rise over the past year, with earnings forecasted to grow by 16% annually. In such a climate, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.

The market remained flat over the last week, yet it is up 18% over the past year, with earnings forecast to grow by 16% annually. Investing in penny stocks—often smaller or newer companies—can still open doors to growth opportunities, particularly when these stocks are backed by strong financial health. This article explores several penny stocks that offer compelling opportunities with less risk than one might expect, showcasing above-average balance sheet resilience.

The United States market remained flat over the last week, but it has risen 18% over the past year with earnings forecasted to grow by 16% annually. In this environment, identifying strong dividend stocks can be an effective strategy for investors seeking stable income and potential capital appreciation.

With inflation still running above the Fed’s 2% target and rate expectations shifting with every new comment from policymakers, many investors are rethinking how to position their portfolios. Defensive sector stocks can sometimes offer a steadier ride when interest rates and bond yields are in focus, because these companies sell essential goods and services that people tend to keep buying. This article looks at three U.S. defensive stocks that are closely exposed to the latest Federal Reserve...

The latest round of Section 301 and Section 338 tariffs is prompting investors to reconsider how exposed portfolios are to complex global supply chains. Higher duties, extra compliance checks and uncertain trade rules can all squeeze margins or re-route production closer to home. That is where a curated US manufacturing and onshoring screener can help focus attention. It filters for larger, financially healthy companies with operations rooted in North America. In this article, you will see...

TriMas Corporation’s recent second-quarter and six-month 2026 results showed slightly higher sales of US$174.58 million and US$342.86 million respectively, alongside lower quarterly net income of US$13.37 million but a very large six‑month net income of US$814.2 million, while continuing its share repurchase program and affirming a US$0.0400 quarterly dividend. Beneath the headline numbers, the combination of improved profitability from continuing operations, a long-running buyback that has...

Capitol Federal Financial, Inc. recently reported third-quarter 2026 results, including US$53.48 million in net interest income, US$23.57 million in net income, minimal net charge-offs of US$148,000, completion of a 9,976,478-share buyback totaling US$72.84 million, and reaffirmed a US$0.085 quarterly dividend per share. Together, higher net interest income, growing net income and the completed share repurchase program underscore management’s clear emphasis on capital return and operating...

MetroCity Bankshares earnings trigger fresh interest MetroCity Bankshares (MCBS) has drawn investor attention after reporting second quarter 2026 results, with net interest income of $44.04 million and net income of $22.13 million, both higher than the prior year period. See our latest analysis for MetroCity Bankshares. MetroCity Bankshares has seen mixed trading around the earnings release, with the share price slipping 4.09% over the past month but still posting a 34.68% year to date share...

Why First Busey’s latest earnings and buyback matter for investors First Busey (BUSE) has drawn fresh attention after second quarter and year to date results showed much higher net income and earnings per share, alongside the completion of a multi year share repurchase program. See our latest analysis for First Busey. At a share price of $30.86, First Busey has delivered a 15.97% 90 day share price return and a 45.10% 1 year total shareholder return, which indicates that recent earnings and...

Eton Pharmaceuticals (ETON) has filed a Prior Approval Supplement with the U.S. Food and Drug Administration to expand KHINDIVI’s label to younger pediatric patients, following bioequivalence data versus ALKINDI SPRINKLE hydrocortisone granules. See our latest analysis for Eton Pharmaceuticals. The KHINDIVI label expansion filing comes after a very strong run in Eton Pharmaceuticals’ stock, with a 30 day share price return of 26.73%, a 90 day share price return of 60.62% and a year to date...

In late July 2026, Myriad Genetics reported second-quarter results showing revenue of US$190.7 million versus US$213.1 million a year earlier, alongside a reduced full-year 2026 revenue outlook of US$770 million to US$790 million due to weaker Prenatal Health test volumes and more cautious assumptions for revenue per test. Despite the revenue decline, the company’s net loss narrowed sharply to US$43.2 million from a very large loss a year ago, highlighting significant cost or non-operational...

In late July 2026, Core Scientific, Inc. reported Q2 2026 revenue of US$164.2 million alongside a net loss of US$1.16 billion, and announced a large‑scale AI infrastructure partnership with Advanced Micro Devices, Inc. involving up to 2.5 gigawatts of potential data center capacity and related stock warrants for Advanced Micro Devices, Inc. Core Scientific, Inc. also added veteran technology executive Mark W. Adams to its expanded seven‑member Board of Directors, strengthening oversight as...

Tariffs on Canadian imports and higher taxes on generic drugs are shaking up expectations for costs and pricing across healthcare. For U.S. specialty pharmaceutical manufacturers, this mix of pressure and opportunity can be important. Some companies may face higher input costs. Others with more domestic production may see a relative edge if imported generics become more expensive. This article explains how the new trade measures could matter for your portfolio and discusses 3 U.S. specialty...

Last week saw the newest quarterly earnings release from BigBear.ai Holdings, Inc. ( NYSE:BBAI ), an important...

With the Federal Reserve sounding more hawkish and futures markets pricing a 72% chance of a rate hike by September, many investors are rethinking where they want their money to work. Higher expected yields on safer assets can change the appeal of riskier choices, including Bitcoin and some growth stocks. In this environment, large U.S. value stocks with lower volatility and modest P/E and P/B ratios can look interesting to some investors. This article walks through 3 U.S. large cap value...

RBC Bearings Incorporated has reported its fiscal first-quarter 2027 results, with net sales rising to US$519.5 million and net income to US$101.5 million, and has issued second-quarter guidance calling for net sales between US$505.0 million and US$515.0 million, implying double-digit year-over-year growth. The combination of strong Aerospace & Defense demand, broad-based Industrial segment growth, and guidance that points to continued operational momentum highlights how current end-market...